Aprea Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
APRE Nasdaq 2836 www.aprea.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aprea Therapeutics, Inc.

Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward - Dec 11th, 2024 1:30 pm
Here's Why Aprea Therapeutics (APRE) Could be Great Choice for a Bottom Fisher - Nov 13th, 2024 2:55 pm
Aprea Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Nov 10th, 2024 1:37 pm
Aprea Therapeutics, Inc. (APRE) Reports Q3 Loss, Lags Revenue Estimates - Nov 7th, 2024 2:20 pm
Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Nov 7th, 2024 1:00 pm
Pacira (PCRX) Q3 Earnings Beat Estimates - Nov 6th, 2024 10:15 pm
Aprea Therapeutics presents preliminary results on APR-1051 - Oct 24th, 2024 12:40 pm
Insider Spends US$132k Buying More Shares In Aprea Therapeutics - Oct 23rd, 2024 6:43 pm
Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics - Oct 23rd, 2024 12:30 pm
Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit - Oct 14th, 2024 12:30 pm
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics - Oct 10th, 2024 12:30 pm
Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development - Oct 9th, 2024 12:30 pm
Aprea Therapeutics to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - Sep 25th, 2024 12:00 pm
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - Sep 20th, 2024 12:35 pm
Life Sciences Virtual Investor Forum Agenda Announced for September 19th - Sep 16th, 2024 4:07 pm
Aprea Therapeutics to Present at the Life Sciences Investor Forum on September 19 - Sep 12th, 2024 12:30 pm
UPDATE - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference - Sep 9th, 2024 9:15 pm
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference - Sep 9th, 2024 8:05 pm
Aprea Therapeutics, Inc. (APRE) Reports Q2 Loss, Tops Revenue Estimates - Aug 12th, 2024 1:45 pm
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Aug 12th, 2024 12:30 pm